Literature DB >> 23892690

Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary.

Alina Denisa Dragan1, Iain J Nixon, Maria Teresa Guerrero-Urbano, Richard Oakley, Jean-Pierre Jeannon, Ricard Simo.   

Abstract

Carcinoma of unknown primary of the neck (CUP) is a metastasis presenting in one or more cervical lymph nodes, with no primary mucosal site identified. Retrospective case notes review of 25 consecutive patients (median age 55, 72% males) diagnosed as CUP who underwent neck dissection in a UK tertiary referral comprehensive cancer centre between 2000 and 2011. Median follow-up was 33 months. Nineteen patients underwent comprehensive neck dissections (six extended), six patients had selective neck dissection. Five year disease specific survival and regional recurrence free survival were 76 and 80% respectively. The overall rate of occult disease (disease not identified on preoperative evaluation, but found on histopathologic examination) was 8%, with rates of 0% in level I and 6% in level V. Our study suggests that in patients without preoperative evidence of disease in levels I or V selective neck dissection might be considered as an option, to facilitate preservation of the submandibular gland and accessory nerve without compromising oncological outcome. Larger studies should be performed before a change in practice can be advised.

Entities:  

Mesh:

Year:  2013        PMID: 23892690     DOI: 10.1007/s00405-013-2643-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Head and neck squamous cell carcinoma from an unknown primary site.

Authors:  Audrey Wallace; Greg M Richards; Paul M Harari; Jessica M Kirwan; Christopher G Morris; Haritha Katakam; William M Mendenhall
Journal:  Am J Otolaryngol       Date:  2010-08-17       Impact factor: 1.808

Review 2.  Neck treatment and shoulder morbidity: still a challenge.

Authors:  Patrick J Bradley; Alfio Ferlito; Carl E Silver; Robert P Takes; Julia A Woolgar; Primož Strojan; Carlos Suárez; Hakan Coskun; Peter Zbären; Alessandra Rinaldo
Journal:  Head Neck       Date:  2010-10-19       Impact factor: 3.147

3.  Quality of life after neck dissection.

Authors:  Hiroyuki Inoue; Ken-Ichi Nibu; Miki Saito; Naoki Otsuki; Haruhiko Ishida; Tetsuro Onitsuka; Takashi Fujii; Kazuyoshi Kawabata; Masahisa Saikawa
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-06

Review 4.  Adjuvant therapy in patients with resected poor-risk head and neck cancer.

Authors:  Jacques Bernier; Jan B Vermorken; Wayne M Koch
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

5.  Positron emission tomography in the management of unknown primary head and neck carcinoma.

Authors:  Frank R Miller; David Hussey; Mural Beeram; Tony Eng; H Stan McGuff; Randal A Otto
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-07

6.  Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT.

Authors:  Florian Keller; Georgios Psychogios; Rainer Linke; Michael Lell; Torsten Kuwert; Heinrich Iro; Johannes Zenk
Journal:  Head Neck       Date:  2010-12-15       Impact factor: 3.147

7.  Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.

Authors:  Marco Cianchetti; Anthony A Mancuso; Robert J Amdur; John W Werning; Jessica Kirwan; Christopher G Morris; William M Mendenhall
Journal:  Laryngoscope       Date:  2009-12       Impact factor: 3.325

8.  Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.

Authors:  Joshua D Waltonen; Enver Ozer; Nathan C Hall; David E Schuller; Amit Agrawal
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-10

9.  Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.

Authors:  Frank R Miller; Anand B Karnad; Tony Eng; David H Hussey; H Stan McGuff; Randal A Otto
Journal:  Head Neck       Date:  2008-01       Impact factor: 3.147

10.  Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.

Authors:  Indira Madani; Luc Vakaet; Katrien Bonte; Tom Boterberg; Wilfried De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-06       Impact factor: 7.038

View more
  3 in total

1.  Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival.

Authors:  Miloslav Pala; Pavla Novakova; Zdena Pechacova; Lucie Vesela; Antonin Vrana; Jarmila Sukova; Petra Holeckova; Tereza Drbohlavova; Tomas Podlesak; Lubos Petruzelka
Journal:  Strahlenther Onkol       Date:  2022-08-09       Impact factor: 4.033

2.  Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines.

Authors:  K Mackenzie; M Watson; P Jankowska; S Bhide; R Simo
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

3.  Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node-negative squamous carcinoma of the oral cavity.

Authors:  Manoj Pandey; Senniappan Karthikeyan; Deepika Joshi; Mohan Kumar; Mridula Shukla
Journal:  World J Surg Oncol       Date:  2018-11-08       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.